Euro biotech market indices in 2002

Combined market capitalisation of Europe's biotech companies dropped by over €30bn, from €80bn at the end of 2000 to just over e50bn at year end 2001.

The findings are published in Endurance, Ernst & Young's European Biotechnology Report 2002.